European Biotechs AbTx and Big Picture Bio Raise Seed Funding for Cancer Therapies
French startup AbTx secured €1.7 million while London-based Big Picture Bio emerged from stealth with €2.55 million, both targeting new approaches to cancer treatment.
AfroEuropa Newsroom
AfroEuropa desk
Two European biotech startups have announced early-stage funding to develop cancer therapies, according to reports from Ventureburn and EU-Startups.
AbTx, a French biotech founded in 2024, raised €1.7 million (about $2 million) in a seed round, as reported by Ventureburn. The company focuses on precision treatments for solid tumors that have not responded to standard care. The funding is intended to support clinical development of its patented Therano-Stick platform, which uses enzymatic bio-conjugation to produce miniaturised antibody-drug conjugates, referred to by the company as fragment drug conjugates. AbTx also received the i-Lab award, which Ventureburn described as public validation for its oncology platform.
Keep reading
Ex-Phoenix Court Partner Launches $17M Solo Fund for European AI Startups
Yvonne Bajela, a former partner at London VC firm Phoenix Court, has closed Evertrue Capital, a $17m debut fund backing pre-seed AI and tech companies across the UK and Europe.
Other highlights
Samsung UK Cuts Galaxy S26 Prices by £250 for Black Friday
Samsung UK has launched a Black Friday campaign reducing prices on several premium Galaxy devices, with phone discounts and trade-in bonuses available.
Follow the story
One newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.
